Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/21/2008WO2008100809A1 Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure
08/21/2008WO2008100803A1 Antihypertensive drug combination
08/21/2008WO2008100727A2 High-dose glycine as a treatment for obsessive-compulsive disorder and obsessive-compulsive spectrum disorders
08/21/2008WO2008100715A1 Aza-isoindolones and their use as metabotropic glutamate receptor potentiators - 613
08/21/2008WO2008100635A1 1- [3- (monocyclic amino) propyl] - 4, 5, 6, 7-tetrahydro-1h-pyrazolo [4, 3-c] -pyridines as modulators of cathepsin s
08/21/2008WO2008100629A2 Glutathione peroxidase mimetics for the treatment of dermatoses
08/21/2008WO2008100628A2 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases
08/21/2008WO2008100627A2 The secreted protein ccdc80 regulates adipocyte differentiation
08/21/2008WO2008100622A2 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
08/21/2008WO2008100620A2 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
08/21/2008WO2008100618A2 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
08/21/2008WO2008100565A1 2-aminopyrimidine modulators of the histamine h4 receptor
08/21/2008WO2008100560A2 Estrogen receptor modulators, associated pharmaceutical compositions and methods of use
08/21/2008WO2008100553A1 Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
08/21/2008WO2008100547A2 Compositions comprising lamiridosin, iridoids or derivatives thereof for treatment of hepatitis c or hepatitis b
08/21/2008WO2008100539A1 Treatment of copd, gastro-esophageal reflux disease (gerd), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, lra drugs, anti-h1 and/or anti-h2 drugs
08/21/2008WO2008100480A1 Functionally selective alpha2c adrenoreceptor agonists
08/21/2008WO2008100463A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
08/21/2008WO2008100459A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
08/21/2008WO2008100458A2 Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa
08/21/2008WO2008100453A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
08/21/2008WO2008100450A2 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
08/21/2008WO2008100448A2 Method of treating cell proliferative disorders using growth hormone secretagogues
08/21/2008WO2008100434A1 Transoral dosage forms comprising sufentanil and naloxone
08/21/2008WO2008100426A2 Substituted pyridine n-oxide herbicides
08/21/2008WO2008100422A1 Compositions comprising mkc-733 (pumosetrag) useful for treating irritable bowel syndrome
08/21/2008WO2008100418A1 Zinc complexes of natural amino acids for treating elevated copper caused toxicities
08/21/2008WO2008100412A1 Piperidine derivatives
08/21/2008WO2008100397A1 Personal lubricant compositions that are free of glycerin and parabens
08/21/2008WO2008100328A2 METHODS AND COMPOSITIONS FOR TARGETING gC1qR/p32
08/21/2008WO2008100301A1 Platinum analogs with bis-nitrile-containing ligands
08/21/2008WO2008100262A1 Medicated feed premix comprising chlortetracycline hydrochloride
08/21/2008WO2008100249A1 Low flush niacin formulation
08/21/2008WO2008100240A2 Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
08/21/2008WO2008100202A1 A 2-f luorobenzoate salt and a 2, 6-dif luorobenzoate salt of n-{5-chloro-2- [ ( (2s) -3-{ [1- (4-chlorobenzyl)piperidin-4- yl ] amino } - 2 - hydroxy- 2 -me t hylpr opyl ) oxy] - 4 - hydroxyphenyl } acetamide
08/21/2008WO2008100130A2 Composition containing kadok extract and collagen
08/21/2008WO2008100107A1 Controlled-release preparation containing cilostazol and process for the preparation thereof
08/21/2008WO2008099944A1 Crystalline forms of thiazolidinedione derivative and its manufacturing method
08/21/2008WO2008099912A1 5ht4 receptor antagonist
08/21/2008WO2008099907A1 Therapeutic agent for urinary excretion disorder
08/21/2008WO2008099906A1 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery
08/21/2008WO2008099902A1 Pyridyl-triazolopyrimidine derivative or its salt, pesticide containing it and its production process
08/21/2008WO2008099883A1 Therapeutic agent for liver cancer
08/21/2008WO2008099874A1 Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
08/21/2008WO2008099853A1 Medicinal composition for promoting periodontal tissue regeneration and agent for promoting periodontal tissue regeneration
08/21/2008WO2008099805A1 Central circulation-improving agent
08/21/2008WO2008099804A1 Therapeutic agent for diabetic cataract
08/21/2008WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma
08/21/2008WO2008099781A1 Therapeutic or prophylactic agent for demyelinating disease comprising amino alcohol derivative as active ingredient
08/21/2008WO2008099615A1 Pharmaceutical composition containing fine particle oil-based suspension
08/21/2008WO2008099492A1 Pyrimidine nucleoside derivative and salt thereof
08/21/2008WO2008099469A1 Composition and method for suppressing lipid peroxidation in erythrocytes
08/21/2008WO2008099448A1 Preventive/therapeutic agent for diabetic diseases
08/21/2008WO2008099426A1 A composition for selective serotonin reuptake inhibition and process thereof
08/21/2008WO2008099416A2 Novel benzothiazole and benzoxazole linked pyrrolo[2,1-c] [1, 4] benzodiazepine hybrids as novel antitumour agents and process for the preparation thereof
08/21/2008WO2008099415A1 Novel substituted bis-1, 2, 4-trioxanes and a process for preparation thereof
08/21/2008WO2008099414A1 NOVEL CATIONIC 17 α- SUBSTITUTED-ESTRADIOL DERIVATIVES USEFUL AS ANTI-CANCER AGENT
08/21/2008WO2008099396A1 Use of h19-silencing nucleic acid agents for treating restenosis
08/21/2008WO2008099368A1 Macrolide derivatives as antibacterial agents
08/21/2008WO2008099278A2 Pharmaceutical compositions and methods for ccr5 antagonists
08/21/2008WO2008099221A1 Amide and urea derivatives for the treatment of metabolic diseases
08/21/2008WO2008099210A2 Piperazine derivatives for treatment of ad and related conditions
08/21/2008WO2008099198A2 Osteogenic compounds
08/21/2008WO2008099190A2 Osteogenic compounds
08/21/2008WO2008099186A1 Heterocyclic derivatives as m3 muscarinic receptors
08/21/2008WO2008099175A1 Camp dependent induction of autophagy
08/21/2008WO2008099165A1 Piperidine derivatives and their use for treatment of ccr8 mediated diseases
08/21/2008WO2008099160A1 Solid oral dosage form containing bicalutamide and method of preparation
08/21/2008WO2008099145A1 Pyrazole derivatives as 11-beta-hsd1 inhibitors
08/21/2008WO2008099144A2 Tgf-beta stimulant and further agent to reduce side effects
08/21/2008WO2008099139A1 1,5-diaryl-pyrazoles as cannabinoid receptor neutral antagonists useful as therapeutic agents
08/21/2008WO2008099091A2 Use of ivabradine for obtaining drugs for treating endothelial dysfunction
08/21/2008WO2008099083A2 Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases
08/21/2008WO2008099082A1 New aminopyrrolo[1,2-α]indole et aminopyridazino[1,6-α]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same
08/21/2008WO2008099076A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
08/21/2008WO2008099075A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors
08/21/2008WO2008099074A1 Phenyl- (4-phenyl-pyrimidin-2-yl) - amine derivatives as ikk inhibitors, preparation thereof, and pharmaceutical compositions thereof
08/21/2008WO2008099073A1 N, n' -2, 4-dianilinopyrimidines preparation and use thereof as ikk inhibitors preparation and teh pharmacuetical compositions thereof
08/21/2008WO2008099025A2 Body-weight maintenance and body composition
08/21/2008WO2008099022A1 10-sulfonyl-dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008WO2008099021A1 Dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008WO2008099020A1 1,1-dioxo-1-thia-5,10-diazadibenzocycloheptenes useful as hepatitis c virus inhibitors
08/21/2008WO2008099019A1 6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008WO2008098995A2 Genes involved in mitochondrial biogenesis
08/21/2008WO2008098992A1 Use of organic compounds
08/21/2008WO2008098985A2 Pharmaceutical composition for the treatment of il-8 mediated diseases
08/21/2008WO2008098977A1 Novel triazole derivatives as ligands of g-protein coupled receptors
08/21/2008WO2008098970A1 Anhydrous crystalline vinflunine salts, method of preparation and use thereof as a drug and means of vinflunine purification
08/21/2008WO2008098960A1 Process for preparing entacapone substantially free of z-isomer, synthesis intermediates thereof and a new crystalline form
08/21/2008WO2008098957A1 Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
08/21/2008WO2008098955A2 Antibacterial combination of a tricyclic carbapenem and an antibiotic
08/21/2008WO2008098892A1 Fast dissociating dopamine 2 receptor antagonists
08/21/2008WO2008098871A2 Use of chitosans for the treatment of nail inflammatory diseases
08/21/2008WO2008098869A2 Use of chitosans to increase nail growth rate
08/21/2008WO2008098859A1 Hcv polymerase inhibitors
08/21/2008WO2008098857A1 2-aminooxazolines as taar1 ligands
08/21/2008WO2008098798A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents
08/21/2008WO2008098751A1 New compounds with antiglutamatergic properties and uses thereof
08/21/2008WO2008098750A1 Pharmaceutical carrier composition and pharmaceutical composition
08/21/2008WO2008098701A1 Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
1 ... 3120 3121 3122 3123 3124 3125 3126 3127 3128 3129 3130 3131 3132 3133 3134 3135 3136 3137 3138 3139 3140 ... 7860